Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 87.17%
March 31, 2026 91.20%
December 31, 2025 86.06%
September 30, 2025 80.40%
June 30, 2025 97.02%
March 31, 2025 89.08%
December 31, 2024 87.39%
September 30, 2024 78.88%
June 30, 2024 93.04%
March 31, 2024 86.46%
December 31, 2023 98.48%
September 30, 2023 89.72%
June 30, 2023 77.00%
March 31, 2023 82.20%
December 31, 2022 75.00%
September 30, 2022 91.72%
June 30, 2022 92.69%
Date Value
March 31, 2022 0.00%
December 31, 2021 77.45%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 0.00%
December 31, 2020 0.00%
September 30, 2020 0.00%
June 30, 2020 0.00%
March 31, 2020 0.00%
December 31, 2019 0.00%
September 30, 2019 0.00%
June 30, 2019 0.00%
March 31, 2019 0.00%
December 31, 2018 0.00%
September 30, 2018 0.00%
December 31, 2017 0.00%
September 30, 2017 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Upstream Bio, Inc. 93.53%
ACADIA Pharmaceuticals, Inc. 90.81%
Alnylam Pharmaceuticals, Inc. 76.88%
Anika Therapeutics, Inc. 65.15%
Savara, Inc. --

Gross Profit Margin (Quarterly) Related Metrics